NCT06757049 (KOREA MITRIS) is a clinical trial in Mitral Valve Insufficiency, sponsored by Asan Medical Center.

Who is sponsoring NCT06757049?

NCT06757049 is sponsored by Asan Medical Center.

What condition does NCT06757049 study?

NCT06757049 studies Mitral Valve Insufficiency.

Is NCT06757049 still recruiting?

NCT06757049 is currently recruiting now. Last updated 3 January 2025.

Last reviewed 2025-01-03 · How we verify

NCT06757049: KOREA MITRIS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Outcomes of Edwards Lifesciences MITRIS RESLILA Mitral Valve in the Asian Population

Recruiting now Last updated 3 January 2025

What this trial tests

trial in Mitral Valve Insufficiency in 200 participants. Currently enrolling.

Timeline

20 December 2024

Primary endpoint
31 March 2031

31 March 2031

Quick facts

Lead sponsor	Asan Medical Center
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	200
Start date	20 December 2024
Primary completion	31 March 2031
Estimated completion	31 March 2031
Sites	1 location across South Korea

Conditions studied

Mitral Valve Insufficiency — all drugs for Mitral Valve Insufficiency →

Sponsor

Asan Medical Center

Who can join

19 and older, any sex, with Mitral Valve Insufficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the early and mid-term safety and performance of the MITRIS RESILIA mitral valve in Asian patients in a real-world setting

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Mitral Valve Insufficiency

Currently open trials in the same condition.

NCT06235385 — European Association of Cardiovascular Imaging Multiple and Mixed Valvular Disease Study · recruiting
NCT05927441 — DragonFly EU Pivotal Study · NA · recruiting
NCT04343313 — The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot Study · NA · recruiting
NCT04153292 — The ENCIRCLE Trial · NA · recruiting
NCT03142152 — The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR · NA · recruiting

Other Asan Medical Center trials

Trials by the same sponsor.

NCT07530393 — Blood Viscosity and Outcomes After Elective Craniotomy · not yet recruiting
NCT07010497 — A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Be · Phase 2 · recruiting
NCT07382505 — Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cerv · not yet recruiting
NCT07489092 — Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge · NA · recruiting
NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06757049 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Asan Medical Center
Last refreshed: 3 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06757049.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing